At admission, most type 1 diabetes patients used some kind of intensified insulin therapy (N = 84, 77%), while only 10% employed Functional (basis/bolus) insulin therapy (FIT), 12% used Conventional insulin therapy (CIT), and only one chose basal insulin alone. The gene discussed is INS; the disease is type 1 diabetes mellitus.